AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]

Biotech company LifeMine Therapeutics has raised $263 million to support [...]

Q32 Bio has reported positive 36-week Phase 2 data showing [...]

Messenger RNA (mRNA) technology could offer a new approach to [...]

bionyra-pharma-series-a-immunology Bionyra Pharma has launched with a $165 million Series [...]

AstraZeneca is presenting a broad package of new clinical and [...]

IMU Biosciences has extended its Series A financing to more [...]

Quotient Therapeutics and Merck sign a multi-year collaboration to identify [...]

Promise Bio has launched the Frontier Epiproteomic Innovation Grant, providing [...]

Affibody has reported positive Phase 1 data from its licensee [...]